Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Tax Rate (2021 - 2025)

Kiniksa Pharmaceuticals International's Tax Rate history spans 5 years, with the latest figure at 14.44% for Q4 2025.

  • For Q4 2025, Tax Rate rose 12664.0% year-over-year to 14.44%; the TTM value through Dec 2025 reached 1076.14%, up 106193.0%, while the annual FY2025 figure was 1076.14%, 106193.0% up from the prior year.
  • Tax Rate reached 14.44% in Q4 2025 per KNSA's latest filing, down from 32.12% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 1308.39% in Q2 2023 to a low of 379.5% in Q3 2022.
  • Average Tax Rate over 5 years is 55.8%, with a median of 3.11% recorded in 2021.
  • Peak YoY movement for Tax Rate: surged 131211bps in 2023, then tumbled -103878bps in 2024.
  • A 5-year view of Tax Rate shows it stood at 0.22% in 2021, then soared by 94884bps to 206.66% in 2022, then plummeted by -112bps to 24.35% in 2023, then crashed by -479bps to 141.08% in 2024, then surged by 90bps to 14.44% in 2025.
  • Per Business Quant, the three most recent readings for KNSA's Tax Rate are 14.44% (Q4 2025), 32.12% (Q3 2025), and 22.05% (Q2 2025).